Low risk of seroconversion or clinical disease in humans after a bite by an Anaplasma phagocytophilum-infected tick

Ticks and Tick-borne Diseases

Volumn 6, Issue 6, 2015, Pages 787-792

  Henningsson, Anna J ^a   Wilhelmsson, Peter ^b   Gyllemark, Paula ^a   Kozak, Monika ^b   Matussek, Andreas ^a   Nyman, Dag ^c   Ekerfelt, Christina ^b   Lindgren, Per Eric ^a,b   Forsberg, Pia ^d  

^a RYHOV COUNTY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c Bimelix Biomedical Laboratory   (Finland)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anaplasama phagocytophilum; Anaplasmosis; Ehrlichiosis; Human; Seroconversion; Tick bite

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANAPLASMA PHAGOCYTOPHILUM; ARTHRALGIA; ARTICLE; BLOOD SAMPLING; BORRELIA BURGDORFERI; CONTROLLED STUDY; FATIGUE; FEMALE; FINLAND; FOLLOW UP; HEADACHE; HUMAN; HUMAN GRANULOCYTIC ANAPLASMOSIS; LYME DISEASE; MYALGIA; NECK PAIN; NONHUMAN; PARESTHESIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; SEROCONVERSION; SWEDEN; TICK BITE; VERTIGO; COMPLICATION; EHRLICHIOSIS; MICROBIOLOGY; PHYSIOLOGY; RISK FACTOR; SCANDINAVIA; TRANSMISSION;

ANAPLASMA PHAGOCYTOPHILUM; BORRELIA BURGDORFERI GROUP; EHRLICHIOSIS; HUMANS; RISK FACTORS; SCANDINAVIAN AND NORDIC COUNTRIES; SEROCONVERSION; TICK BITES;

EID: 84942305865     PISSN: 1877959X     EISSN: 18779603     Source Type: Journal    
DOI: 10.1016/j.ttbdis.2015.07.005     Document Type: Article

References (55)

1. Aguero-Rosenfeld M.E., Donnarumma L., Zentmaier L., Jacob J., Frey M., Noto R., Carbonaro C.A., Wormser G.P. Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J. Clin. Microbiol. 2002, 40:2612-2615.
2. Aguero-Rosenfeld M.E. Laboratory aspects of tick-borne diseases: lyme, human granulocytic ehrlichiosis and babesiosis. Mt. Sinai J. Med. 2003, 70:197-206.
3. Bakken J.S., Krueth J., Tilden R.L., Dumler J.S., Kristiansen B.E. Serological evidence of human granulocytic ehrlichiosis in Norway. Eur. J. Clin. Microbiol. Infect. Dis. 1996, 15:829-832.
4. Bakken J.S., Krueth J., Wilson-Nordskog C., Tilden R.L., Asanovich K., Dumler J.S. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996, 275:199-205.
5. Bakken J.S., Haller I., Riddell D., Walls J.J., Dumler J.S. The serological response of patients infected with the agent of human granulocytic ehrlichiosis. Clin. Infect. Dis. 2002, 34:22-27.
6. Belongia E.A., Reed K.D., Mitchell P.D., Chyou P.H., Mueller-Rizner N., Finkel M.F., Schriefer M.E. Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin. Clin. Infect. Dis. 1999, 29:1472-1477.
7. Bjoersdorff A., Berglund J., Kristiansen B.E., Soderstrom C., Eliasson I. Varying clinical picture and course of human granulocytic ehrlichiosis. Twelve Scandinavian cases of the new tick-borne zoonosis are presented. Lakartidningen 1999, 96:4200-4204.
8. Bjoersdorff A., Brouqui P., Eliasson I., Massung R.F., Wittesjo B., Berglund J. Serological evidence of Ehrlichia infection in Swedish Lyme borreliosis patients. Scand. J. Infect. Dis. 1999, 31:51-55.
9. Bjoersdorff A., Wittesjo B., Berglund J., Massung R.F., Eliasson I. Human granulocytic ehrlichiosis as a common cause of tick-associated fever in southeast Sweden: report from a prospective clinical study. Scand. J. Infect. Dis. 2002, 34:187-191.
10. Blanco J.R., Oteo J.A. Human granulocytic ehrlichiosis in Europe. Clin. Microbiol. Infect. 2002, 8:763-772.
11. Capligina V., Salmane I., Keiss O., Vilks K., Japina K., Baumanis V., Ranka R. Prevalence of tick-borne pathogens in ticks collected from migratory birds in Latvia. Ticks Tick Borne Dis. 2014, 5:75-81.
12. Centers for Disease Control and Prevention Summary of notifiable diseases - United States. MMWR 60:1-117 (cited January 2015) 2011, Available from: http://www.cdc.gov/mmwr/mmwr_nd/.
13. Chen S.M., Dumler J.S., Bakken J.S., Walker D.H. Identification of a granulocytotropic ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 1994, 32:589-595.
14. Coipan E.C., Jahfari S., Fonville M., Maassen C.B., van der Giessen J., Takken W., Takumi K., Sprong H. Spatiotemporal dynamics of emerging pathogens in questing Ixodes ricinus. Front. Cell. Infect. Microbiol. 2013, 3:36.
15. Dahlgren F.S., Mandel E.J., Krebs J.W., Massung R.F., McQuiston J.H. Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000-2007. Am. J. Trop. Med. Hyg. 2011, 85:124-131.
16. Dumler J.S., Dotevall L., Gustafson R., Granstrom M. A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden. J. Infect. Dis. 1997, 175:720-722.
17. Dumler J.S., Madigan J.E., Pusterla N., Bakken J.S. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin. Infect. Dis. 2007, 45(Suppl. 1):S45-S51.
18. Egenvall A.E., Hedhammar A.A., Bjoersdorff A.I. Clinical features and serology of 14 dogs affected by granulocytic ehrlichiosis in Sweden. Vet. Rec. 1997, 140:222-226.
19. Fryland L., Wilhelmsson P., Lindgren P.E., Nyman D., Ekerfelt C., Forsberg P. Low risk of developing Borrelia burgdorferi infection in the south-east of Sweden after being bitten by a Borrelia burgdorferi-infected tick. Int. J. Infect. Dis. 2011, 15:e174-e181.
20. Goodman J.L., Nelson C., Vitale B., Madigan J.E., Dumler J.S., Kurtti T.J., Munderloh U.G. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 1996, 334:209-215.
21. Grankvist A., Andersson P.O., Mattsson M., Sender M., Vaht K., Hoper L., Sakiniene E., Trysberg E., Stenson M., Fehr J., Pekova S., Bogdan C., Bloemberg G., Wenneras C. Infections with the tick-borne bacterium "Candidatus Neoehrlichia mikurensis" mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases. Clin. Infect. Dis. 2014, 58:1716-1722.
22. Gray J., Stanek G., Kundi M., Kocianova E. Dimensions of engorging Ixodes ricinus as a measure of feeding duration. Int. J. Med. Microbiol. 2005, 295:567-572.
23. Horowitz H.W., Aguero-Rosenfeld M.E., Holmgren D., McKenna D., Schwartz I., Cox M.E., Wormser G.P. Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Clin. Infect. Dis. 2013, 56:93-99.
24. Huhn C., Winter C., Wolfsperger T., Wüppenhorst N., Strasek Smrdel K., Skuballa J., Pfäffle M., Petney T., Silhagi C., Dyachenko V., Pantchev N., Straubinger R.K., Schaarschmidt-Kiener D., Ganter M., Aardema M.L., von Loewenich F.D. Analysis of the population structure of Anaplasma phagocytophilum using multilocus sequence typing. PLOS ONE 2014, 9(4):e93725.
25. Jereb M., Pecaver B., Tomazic J., Muzlovic I., Avsic-Zupanc T., Premru-Srsen T., Levicnik-Stezinar S., Karner P., Strle F. Severe human granulocytic anaplasmosis transmitted by blood transfusion. Emerg. Infect. Dis. 2012, 18:1354-1357.
26. Jin H., Wei F., Liu Q., Qian J. Epidemiology and control of human granulocytic anaplasmosis: a systematic review. Vector Borne Zoonotic Dis. 2012, 12:269-274.
27. Karlsson U., Bjoersdorff A., Massung R.F., Christensson B. Human granulocytic ehrlichiosis - a clinical case in Scandinavia. Scand. J. Infect. Dis. 2001, 33:73-74.
28. Katavolos P., Armstrong P.M., Dawson J.E., Telford S.R. Duration of tick attachment required for transmission of granulocytic ehrlichiosis. J. Infect. Dis. 1998, 177:1422-1425.
29. Krause P.J., McKay K., Thompson C.A., Sikand V.K., Lentz R., Lepore T., Closter L., Christianson D., Telford S.R., Persing D., Radolf J.D., Spielman A. Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin. Infect. Dis. 2002, 34:1184-1191.
30. Lindblom P., Wilhelmsson P., Fryland L., Sjowall J., Haglund M., Matussek A., Ernerudh J., Vene S., Nyman D., Andreassen A., Forsberg P., Lindgren P.E. Tick-borne encephalitis virus in ticks detached from humans and follow-up of serological and clinical response. Ticks Tick Borne Dis. 2014, 5:21-28.
31. Lotric-Furlan S., Petrovec M., Zupanc T.A., Nicholson W.L., Sumner J.W., Childs J.E., Strle F. Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia. Clin. Infect. Dis. 1998, 27:424-428.
32. Massung R.F., Mauel M.J., Owens J.H., Allan N., Courtney J.W., Stafford K.C., Mather T.N. Genetic variants of Ehrlichia phagocytophila Rhode Island and Connecticut. Emerg. Infect. Dis. 2002, 8:467-472.
33. Nadelman R.B., Horowitz H.W., Hsieh T.C., Wu J.M., Aguero-Rosenfeld M.E., Schwartz I., Nowakowski J., Varde S., Wormser G.P. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N. Engl. J. Med. 1997, 337:27-30.
34. Petrovec M., Lotric Furlan S., Zupanc T.A., Strle F., Brouqui P., Roux V., Dumler J.S. Human disease in Europe caused by a granulocytic Ehrlichia species. J. Clin. Microbiol. 1997, 35:1556-1559.
35. Piesman J., Mather T.N., Sinsky R.J., Spielman A. Duration of tick attachment and Borrelia burgdorferi transmission. J. Clin. Microbiol. 1987, 25:557-558.
36. Rar V., Golovljova I. Anaplasma, Ehrlichia, and "Candidatus Neoehrlichia" bacteria: pathogenicity, biodiversity, and molecular genetic characteristics, a review. Infect. Genet. Evol. 2001, 11:1842-1861.
37. Schicht S., Junge S., Schnieder T., Strube C. Prevalence of Anaplasma phagocytophilum and coinfection with Borrelia burgdorferi sensu lato in the hard tick Ixodes ricinus in the city of Hanover (Germany). Vector Borne Zoonotic Dis. 2011, 11:1595-1597.
38. Schotthoefer A.M., Meece J.K., Fritsche T.R. A clinical, diagnostic, and ecologic perspective on human anaplasmosis in the Upper Midwest. WMJ 2014, 113:107-114. quiz 115.
39. Schwaiger M., Cassinotti P. Development of a quantitative real-time RT-PCR assay with internal control for the laboratory detection of tick borne encephalitis virus (TBEV) RNA. J. Clin. Virol. 2003, 27:136-145.
40. Severinsson K., Jaenson T.G., Pettersson J., Falk K., Nilsson K. Detection and prevalence of Anaplasma phagocytophilum and Rickettsia helvetica in Ixodes ricinus ticks in seven study areas in Sweden. Parasites Vectors 2010, 3:66.
41. Skarphedinsson S., Sogaard P., Pedersen C. Seroprevalence of human granulocytic ehrlichiosis in high-risk groups in Denmark. Scand. J. Infect. Dis. 2001, 33:206-210.
42. Soleng A., Kjelland V. Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in Ixodes ricinus ticks in Bronnoysund in northern Norway. Ticks Tick Borne Dis. 2013, 4:218-221.
43. Steere A.C., McHugh G., Suarez C., Hoitt J., Damle N., Sikand V.K. Prospective study of coinfection in patients with erythema migrans. Clin. Infect. Dis. 2003, 36:1078-1081.
44. Strle F. Human granulocytic ehrlichiosis in Europe. Int. J. Med. Microbiol. 2004, 293(Suppl. 37):27-35.
45. Stuen S. Anaplasma phagocytophilum - the most widespread tick-borne infection in animals in Europe. Vet. Res. Commun. 2007, 31(Suppl. 1):79-84.
46. Stuen S., Van De Pol I., Bergstrom K., Schouls L.M. Identification of Anaplasma phagocytophila (formerly Ehrlichia phagocytophila) variants in blood from sheep in Norway. J. Clin. Microbiol. 2002, 40:3192-3197.
47. Thomas V., Anguita J., Barthold S.W., Fikrig E. Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect. Immun. 2001, 69:3359-3371.
48. Tijsse-Klasen E., Jacobs J.J., Swart A., Fonville M., Reimerink J.H., Brandenburg A.H., van der Giessen J.W., Hofhuis A., Sprong H. Small risk of developing symptomatic tick-borne diseases following a tick bite in The Netherlands. Parasites Vectors 2011, 4:17.
49. Tveten Y. Prevalence and diversity among Anaplasma phagocytophilum strains originating from Ixodes ricinus ticks from Northwest Norway. J. Pathol. 2014, Article ID 824897. 10.1155/2014/824897.
50. Walder G., Tiwald G., Dierich M.P., Wurzner R. Serological evidence for human granulocytic ehrlichiosis in Western Austria. Eur. J. Clin. Microbiol. Infect. Dis. 2003, 22:543-547.
51. van Dobbenburgh A., van Dam A.P., Fikrig E. Human granulocytic ehrlichiosis in western Europe. N. Engl. J. Med. 1999, 340:1214-1216.
52. Welinder-Olsson C., Kjellin E., Vaht K., Jacobsson S., Wenneras C. First case of human "Candidatus Neoehrlichia mikurensis" infection in a febrile patient with chronic lymphocytic leukemia. J. Clin. Microbiol. 2010, 48:1956-1959.
53. Wilhelmsson P., Fryland L., Borjesson S., Nordgren J., Bergstrom S., Ernerudh J., Forsberg P., Lindgren P.E. Prevalence and diversity of Borrelia species in ticks that have bitten humans in Sweden. J. Clin. Microbiol. 2010, 48:4169-4176.
54. Wilhelmsson P., Lindblom P., Fryland L., Ernerudh J., Forsberg P., Lindgren P.E. Prevalence, diversity, and load of Borrelia species in ticks that have fed on humans in regions of Sweden and Aland Islands, Finland with different Lyme borreliosis incidences. PLOS ONE 2013, 8:e81433.
55. Wittesjö B., Bjoersdorff A., Eliasson I., Berglund J. First long-term study of the seroresponse to the agent of human granulocytic ehrlichiosis among residents of a tick-endemic area of Sweden. Eur. J. Clin. Microbiol. Infect. Dis. 2001, 20:173-178.